What does ceftriaxone mean that basic medicines tender for less than one dollar?

A comparison of the lowest bid price of ceftriaxone sodium for injection in some provinces in the first half of 2011 (yuan/branch)

In recent days, in 2011, a basic medical and health institution in a province's primary health care institutions issued a bid to bid for the basic bid, and the minimum bid opening price of 1.0g ceftriaxone sodium 0.847 yuan/branch was launched.

what does this mean? The knowledgeable person knows that the account will know that the injection of ceftriaxone sodium 1.0g / support specifications, packaging materials at least 0.25 yuan, 0.12 yuan tax, the remaining 0.477 yuan fully counted as the cost of ceftriaxone sodium sterile powder, converted into Cephyi Pine sodium drug price is 487 yuan / kg. Do you believe it? In any case, I do not believe that this kind of cheap medicine can be done, nor do I believe that this medicine can relieve the burden on the patient.

Go back and look at the difference in bid prices between the last year and this year for ceftriaxone injections in the provinces. A comparative analysis of the successful bid database accumulated by Beijing Dongfang Bit Technology Co., Ltd. reveals that: First, the bid price of ceftriaxone for injection is up to 1 times the highest difference in less than two years, and the cost of manufacturing companies is falling at such a rapid rate. It is truly surprising. Second, the regional price difference is up to 1 times. What is the disparity in the regional differences? Is it that the host's tender weight is still in quality?

We can't help but ask: Will patients really benefit after taking turns? Can it really reduce the burden? Is it really the purpose of medical reform? Basic medicine is reimbursed for medication. Since it is a medical insurance reimbursement, patients can't really spend much money to use this kind of medicine. Can they show that these low-priced base medicines can solve the problem of ordinary people paying for medicine?

The bidding price is set so low. What do you rely on for clinical services? Competing prices, bad money drive good money, so the wind brings consequences will make some companies take the risk, give up the credibility, sacrifice quality. In addition to the companies that have no profits in the formulation business, companies that have been involved in the raw material intermediates in the upstream have not had a good day, and they have no benefit to the industry. Pharmaceutical companies still have profit margins, or can press water again. As the costs of raw materials and human resources continue to increase, the pharmaceutical industry is not misunderstood by the outside world. The cost of drugs is like squeezed water from sponges. It is believed that the successful bidder must also have destroyed his teeth and swallowed.

What is the space for enterprise cost reduction? Do not implement GMP, do not consider the interests of employees, do not need to invest in management, do not have social responsibility? If so, how can China's pharmaceutical industry continue to develop?